Vaxxas Awarded US$3.67 million (AU$5.4 million) from global

Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch

Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Australia , Australian , Jaeyong Ahn , Davidl Hoey , Pierre Balard , Development Authority , Oneventures Innovation Fund , Senior Research , Wellcome , United States Biomedical Advanced Research , Melinda Gates Foundation , Australian Government Innovation Investment Fund , International Vaccine Institute , World Health Organization , University Of Queensland , Human Clinical Study , Typhoid Vaccination , Needle Free Vaccine , Salmonella Typhi , Senior Research Manager , Melinda Gates , Drug Safety , Brandon Capital Partners , Healthcare Ventures , Brandon Biocatalyst , Australian Government , Innovation Investment Fund ,